Skip to main content

Table 4 Results of staff questionnaires (n = 13)

From: Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study

  Strongly agree Agree Neutral Disagree Strongly disagree Not applicable
ADMINISTRATION_A: It was acceptable to give out information to patients in clinic 4 (31%) 7 (54%) 1 (8%) 1 (8%) 0 (0%) 0 (0%)
ADMINISTRATION_B: There was enough time to collect the additional patient data 1 (8%) 3 (23%) 8 (62%) 1 (8%) 0 (0%) 0 (0%)
ADMINISTRATION_C: I felt confident collecting the additional patient data 3 (23%) 6 (46%) 4 (31%) 0 (0%) 0 (0%) 0 (0%)
ADMINISTRATION_D: There was enough time to collect the patient questionnaires 0 (0%) 4 (31%) 5 (38%) 2 (15%) 1 (8%) 1 (8%)
ADMINISTRATION_E: I felt confident collecting the patient questionnaires 2 (15%) 9 (69%) 2 (15%) 0 (0%) 0 (0%) 0 (0%)
TRAINING_A: After training I understand how to collect the mouth swab 7 (54%) 5 (38%) 0 (0%) 0 (0%) 0 (0%) 1 (8%)1
TRAINING_B: After training I understand how to transfer cells into the reactor tray using the sample collector 7 (54%) 5 (38%) 0 (0%) 0 (0%) 0 (0%) 1 (8%)1
TRAINING_C: After training I understand how to seal and load the reactive tray into the para-DNA machine 7 (54%) 5 (38%) 0 (0%) 0 (0%) 0 (0%) 1 (8%)1
TRAINING_D: After training I understand how to use the dose calculator programme 6 (46%) 6 (46%) 0 (0%) 0 (0%) 0 (0%) 1 (8%)1
TRAINING_E: After training I felt confident to initiate genotype-guided dosing of warfarin to patients 6 (46%) 5 (38%) 1 (8%) 0 (0%) 0 (0%) 1 (8%)1
PROCESS_A: The timing of the genotype-guided dosing system fits in well with the running of the clinic 1 (8%) 1 (8%) 3 (23%) 6 (46%) 2 (15%) 0 (0%)
PROCESS_B: The patients needed to wait or return to clinic after 50 min to receive their warfarin dose and this fitted in well with the running of the clinic 0 (0%) 3 (23%) 2 (15%) 5 (38%) 2 (15%) 1 (8%)
PROCESS_C: Patients returned a few days later to have their warfarin dose adjusted and this fitted in well with the running of the clinic 1 (8%) 3 (23%) 3 (23%) 6 (46%) 0 (0%) 0 (0%)
PROCESS_D: The implementation of genotype-guided dosing for warfarin was worth doing to improve the dosing for patients 1 (8%) 2 (15%) 7 (54%) 3 (23%) 0 (0%) 0 (0%)
PROCESS_E: Overall the genotype-guided dosing of warfarin appeared to be acceptable to our patients 0 (0%) 7 (54%) 4 (31%) 2 (15%) 0 (0%) 0 (0%)
  1. 1Healthcare assistant not involved in the procedures for which training required